missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Rat Erythropoietin/EPO Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Marca: R&D Systems™ 1306-RE-010/CF
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
The Recombinant Rat Erythropoietin Protein is derived from Sf 21 (stably transfected). The Recombinant Rat Erythropoietin Protein has been validated for the following applications: Bioactivity.Especificaciones
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| 18.5 kDa | |
| 10 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| ECYT5, EP, EPO, epoetin, erythropoietin, MGC138142, MVCD2 | |
| Recombinant |
| 24335 | |
| Erythropoietin/EPO | |
| Spodoptera frugiperda, Sf 21 (stably transfected)-derived rat Erythropoietin/EPO protein Ala27-Arg192 | |
| <0.10 EU per 1μg of the protein by the LAL method. | |
| Unconjugated | |
| >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido